Sand Hill Angels

VIAN Therapeutics is an early-stage biotechnology company dedicated to innovating treatments for retinal diseases. The company is developing a first-in-class, non-invasive eyedrop intended to replace traditional injections for conditions such as age-related macular degeneration and diabetic macular edema. With robust preclinical data and ongoing clinical trials, VIAN aims to meet significant unmet medical needs in the retinal disease market, which is valued at $15 billion. Additionally, the company is engaged in the creation of peptide drugs that enhance efficacy and safety for treating both ophthalmic and oncology-related conditions by targeting angiogenesis, thereby offering patients improved health outcomes.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Sonavi Labs, Inc. is a Baltimore-based company that specializes in the development of medical devices and artificial intelligence-based software aimed at respiratory monitoring and diagnostic support. Founded in 2017, the company focuses on creating innovative products that analyze body sounds to assist in the diagnosis of respiratory diseases. By leveraging advanced technology, Sonavi Labs enables healthcare providers to detect, monitor, and potentially predict respiratory conditions by identifying abnormalities in the sounds produced by the body. This approach enhances the capabilities of medical professionals and aims to improve the patient experience in managing respiratory health.

Thread Robotics provides medical devices and services with a focus on fertility care. It was founded in 2020 and operates in Mountain View, California.

Nanochon is focused on creating innovative implantable medical devices designed to address cartilage damage in joints. Utilizing advanced 3D printing techniques and a unique nanomaterial, the company aims to develop solutions that not only replace lost and damaged cartilage but also promote the growth of new tissue. This approach allows medical practitioners to access cost-effective and on-demand devices that enhance treatment outcomes, particularly for young and active patients suffering from knee injuries and diseases. Through its technology, Nanochon seeks to improve the overall quality of care in orthopedics.

Thirty Madison, Inc. is a digital health company based in Astoria, New York, that operates web-based platforms tailored to patients with chronic conditions. Founded in 2016, the company offers a range of specialized healthcare brands, including Keeps for men’s hair loss, Cove for migraines, Picnic for allergies, Facet for skin conditions, and NURX for sexual health. Each brand is designed to provide personalized treatments and care, addressing the unique needs of its community. By focusing on specific ongoing conditions, Thirty Madison seeks to empower individuals through accessible and effective healthcare solutions, facilitating exceptional outcomes for patients over a lifetime of care.

SDIP Innovations specializes in the development and manufacturing of bioresorbable bone implants designed for bone repair and replacement. These innovative implants mimic the natural bone remodeling process, facilitating the healing of fractured bones without the need for surgical removal after their purpose has been served. As the implants are fully absorbed by the body, they promote tissue regeneration while providing a biologically natural and chemically neutral environment conducive to bone renewal. This technology enables surgeons to perform critical surgeries and treat fractures more effectively, enhancing patient recovery and outcomes.

BrightInsight operates a digital health platform tailored for biopharma and medtech companies, focusing on the development and optimization of regulated drugs, devices, and software. Founded in 2017 and headquartered in San Jose, California, the company offers a global regulated platform that utilizes Internet of Things (IoT) technology. This platform facilitates the capture, transmission, and analysis of data from connected medical devices, combination products, and digital therapeutics. By adhering to rigorous security, privacy, and regulatory standards, BrightInsight enables its clients to enhance patient adherence and engagement, streamline their processes, and accelerate time to market while reducing implementation costs. With an additional office in Hägglingen, Switzerland, BrightInsight is positioned to support customers in navigating the complexities of the digital health landscape.

Profusa, Inc. operates in the health care sector. It is dedicated to the development of a new generation of biointegrated sensors that empowers the individual with the ability to monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. The company was incorporated in 2009 and is based in Cupertino, California.

Medly Pharmacy Inc. is a digital pharmacy based in Brooklyn, New York, with a satellite office in New Jersey, specializing in free same-day delivery of prescriptions across New York City and New Jersey. Founded in 2017, the pharmacy provides a comprehensive range of services, including prescription refills, coordination with healthcare providers and insurance companies, prior authorization support, and financial assistance. Medly Pharmacy combines personalized customer service with extensive pharmacy expertise to enhance the care experience for patients. Its user-friendly mobile application allows customers to track deliveries and communicate easily with pharmacy staff, ensuring a hassle-free process for obtaining medications.

Lambs is a company that specializes in designing and developing protective apparel aimed at shielding individuals from wireless radiation. The brand is particularly known for its high-tech boxers that protect male reproductive health by minimizing exposure to cellphone and Wi-Fi radiation. Utilizing advanced material science and performance fabrics, Lambs creates a variety of clothing items, including undergarments, t-shirts, socks, and face masks, all focused on providing both comfort and protection against harmful radiation. The company's innovative approach reflects its commitment to combining style with functionality in everyday wear.

Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Imprint Energy, Inc. develops and commercializes innovative zinc-based rechargeable battery technology aimed at enhancing portable power solutions. The company offers ZincPoly batteries, which address the limitations of traditional zinc batteries and enable the production of rechargeable options. These batteries are designed for a variety of small portable electronics, including mobile accessories, compact wireless devices, wearables, and medical equipment. Founded in 2010 and based in Alameda, California, Imprint Energy focuses on providing flexible, high-energy-density batteries that deliver lithium-like performance at lower costs, while also prioritizing safety and scalability through a unique print-based manufacturing process. This breakthrough technology positions Imprint Energy to meet the evolving energy needs of contemporary and future electronic devices.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Profusa, Inc. operates in the health care sector. It is dedicated to the development of a new generation of biointegrated sensors that empowers the individual with the ability to monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. The company was incorporated in 2009 and is based in Cupertino, California.

Thirty Madison, Inc. is a digital health company based in Astoria, New York, that operates web-based platforms tailored to patients with chronic conditions. Founded in 2016, the company offers a range of specialized healthcare brands, including Keeps for men’s hair loss, Cove for migraines, Picnic for allergies, Facet for skin conditions, and NURX for sexual health. Each brand is designed to provide personalized treatments and care, addressing the unique needs of its community. By focusing on specific ongoing conditions, Thirty Madison seeks to empower individuals through accessible and effective healthcare solutions, facilitating exceptional outcomes for patients over a lifetime of care.

Fitnescity is a consumer health platform that simplifies access to health and wellness testing services. The company offers a range of test kits that are utilized by prominent laboratories, hospitals, and clinics across the country. These kits facilitate consumer-facing tests, including assessments for vitamin D, testosterone, glucose, body composition, creatinine, and resting metabolic rate. By providing both at-home and in-person testing options, Fitnescity enables individuals to easily navigate their health and fitness needs, empowering them to make informed decisions regarding their wellness and performance.

Siren Care, Inc. is a health technology company based in San Francisco, California, founded in 2015. It specializes in wearable devices designed for diabetic health tracking, particularly through its flagship product, the Siren diabetic socks. These smart socks continuously monitor foot temperature, providing crucial data that can help detect early signs of diabetic ulcers, thereby reducing the risk of amputations. The temperature data is transmitted via an application, allowing healthcare providers to monitor patients effectively and intervene early if necessary. Siren Care aims to enhance healthcare for individuals with chronic diseases by collaborating with both providers and payers to improve patient outcomes in diabetic foot care.

Sonavi Labs, Inc. is a Baltimore-based company that specializes in the development of medical devices and artificial intelligence-based software aimed at respiratory monitoring and diagnostic support. Founded in 2017, the company focuses on creating innovative products that analyze body sounds to assist in the diagnosis of respiratory diseases. By leveraging advanced technology, Sonavi Labs enables healthcare providers to detect, monitor, and potentially predict respiratory conditions by identifying abnormalities in the sounds produced by the body. This approach enhances the capabilities of medical professionals and aims to improve the patient experience in managing respiratory health.

Anzu is an exciting, fast-growing startup founded by a group of physicians and technologists with a shared vision for creating inspiring products to benefit medical practices, doctors and patients. Headquartered in Phoenix, with operations in Boston, Silicon Valley and India, Anzu is privately held.

Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company specializes in developing gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company is committed to advancing these therapeutics to ensure they are safe and effective, with the goal of significantly improving the lives of individuals affected by viral infections worldwide.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company focuses on creating consumer-friendly products that activate the body's natural healing mechanisms, offering an alternative to traditional pharmaceutical treatments. Its flagship product, ClearUP Sinus Pain Relief, is a patented handheld device designed to provide temporary relief from sinus pain and congestion associated with nasal allergies and sinus infections. The device employs ultra-low current electrical waves and has been clinically validated for its efficacy. Tivic Health received FDA clearance for ClearUP in January 2019, with the product set to be shipped starting in September 2019.

Mindshare Medical is focused on the development of evidence-based clinical decision support technology solutions. The company’s proprietary solution provides personalized diagnostics and guidance on the effectiveness of follow-up procedures and treatments. This approach is intended to improve quality of patient care and reduce financial liability for healthcare organizations. Mindshare Medical was founded by Samir Chowdhury and Michael Calhoun in May 2014.

NS Nanotech Inc., founded in 2018 and located in Ann Arbor, Michigan, specializes in developing innovative nano-LED technology for various applications, including display systems, UV sterilization, and carbon water splitting. The company has patented nitride semiconductors that produce light in both the visible RGB spectrum and the invisible UV spectrum, targeting next-generation display technology, such as signage, mobile devices, augmented reality, virtual reality, and high-definition televisions. NS Nanotech's solid-state technology aims to replace traditional germicidal UVC lamps, which are often large, fragile, and costly, and typically contain hazardous materials like mercury. The company's nano-LED products utilize nanowires in photonic crystal structures to achieve efficient battery life and cost-effective device fabrication, making them suitable for air, surface, and water purification applications.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

JUUL is an electronics company based in San Francisco that focuses on providing alternatives for adult smokers through its nicotine vaporizer products. Founded with the mission to eliminate combustible cigarettes, JUUL aims to offer a viable solution for the approximately one billion smokers worldwide. The company's offerings include a range of vapes and various free-base nicotine flavors derived from natural oils and extracts, designed to deliver a satisfying smoking experience while reducing the harmful effects associated with traditional tobacco use. JUUL has reported that hundreds of thousands of smokers have successfully transitioned to its products, with plans to support millions more in making the switch in the future.

InnoVein, Inc. is a medical device company founded in 2015 and based in San Carlos, California. The company specializes in developing an implantable valve designed to regulate blood flow in the veins, particularly targeting elderly patients suffering from venous insufficiency disease. With a focus on advancing cardiac and arterial health, InnoVein aims to address critical needs in vascular treatment through its innovative product offerings.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Flux Bioscience is a company that originated from Stanford University, focusing on innovative point-of-care in vitro medical diagnostics. It has developed a portable biosensor platform designed to deliver medical-grade diagnostics directly to patients' homes. Utilizing a technology initially designed for reading and writing computer hard drives, Flux's platform analyzes blood, urine, or saliva samples to measure various biomarkers related to exercise, stress, fertility, and diet. These measurements are correlated with sleep and activity data obtained from wearable technologies. The biosensors are equipped with biochips that can detect multiple biomarkers simultaneously, providing accurate and sensitive real-time results through antibody-antigen interactions with magnetic nanoparticles. This approach empowers individuals to take charge of their healthcare and make informed lifestyle decisions.

Kenzen, Inc. specializes in health and performance monitoring through its innovative Kenzen ECHO system, which includes a wireless smart patch designed to provide real-time feedback on vital signs, motion, and performance. The smart patch continuously monitors critical parameters to detect heat-related injuries and alert both users and safety supervisors, thereby enhancing workplace safety. Kenzen ECHO also incorporates a mobile application that delivers personalized health insights, aiding in performance improvement and injury prevention. The company, which was incorporated in 2014 and is based in New York, markets its products through various distributors, resellers, and retail locations. Its mission focuses on leveraging physiological data to predict and prevent injuries among industrial workers, ultimately boosting productivity and ensuring safer work environments.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company focuses on creating consumer-friendly products that activate the body's natural healing mechanisms, offering an alternative to traditional pharmaceutical treatments. Its flagship product, ClearUP Sinus Pain Relief, is a patented handheld device designed to provide temporary relief from sinus pain and congestion associated with nasal allergies and sinus infections. The device employs ultra-low current electrical waves and has been clinically validated for its efficacy. Tivic Health received FDA clearance for ClearUP in January 2019, with the product set to be shipped starting in September 2019.

Sandstone Diagnostics offers a centrifuge system that provides plasma and serum collection at-home and the point-of-care. It specializes in the fields of clinical diagnostics, home healthcare, and fertility. It was founded in 2012 and headquartered in Pleasanton, California.

ProbiusDx Inc. is a manufacturer of portable diagnostic devices that utilize an electronic sensing platform to analyze multiple target proteins in real time. This technology allows healthcare professionals to detect and monitor blood concentrations, facilitating timely and appropriate therapy for patients requiring critical care in clinical settings. Founded in 2015 and based in El Cerrito, California, ProbiusDx aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.

JUUL is an electronics company based in San Francisco that focuses on providing alternatives for adult smokers through its nicotine vaporizer products. Founded with the mission to eliminate combustible cigarettes, JUUL aims to offer a viable solution for the approximately one billion smokers worldwide. The company's offerings include a range of vapes and various free-base nicotine flavors derived from natural oils and extracts, designed to deliver a satisfying smoking experience while reducing the harmful effects associated with traditional tobacco use. JUUL has reported that hundreds of thousands of smokers have successfully transitioned to its products, with plans to support millions more in making the switch in the future.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company focuses on creating consumer-friendly products that activate the body's natural healing mechanisms, offering an alternative to traditional pharmaceutical treatments. Its flagship product, ClearUP Sinus Pain Relief, is a patented handheld device designed to provide temporary relief from sinus pain and congestion associated with nasal allergies and sinus infections. The device employs ultra-low current electrical waves and has been clinically validated for its efficacy. Tivic Health received FDA clearance for ClearUP in January 2019, with the product set to be shipped starting in September 2019.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Sandstone Diagnostics offers a centrifuge system that provides plasma and serum collection at-home and the point-of-care. It specializes in the fields of clinical diagnostics, home healthcare, and fertility. It was founded in 2012 and headquartered in Pleasanton, California.

RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. It focuses on developing innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. The company's flagship product, the RenovoCath, is designed for use in the visceral and peripheral vascular systems and has received FDA clearance for clinical use. RenovoRx aims to enhance therapeutic outcomes for cancer patients through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while potentially reducing systemic side effects. The company is supported by a dedicated management team and an advisory board composed of experts in interventional radiology, surgical oncology, and gastroenterology, providing guidance for its clinical development strategies.

Cadence Biomedical, headquartered in Seattle, WA, is an early-stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life. Cadence Biomedical's primary commercial product, Kickstart, is a neurorehabilitation device designed to accelerate recovery to walking in stroke, multiple sclerosis, spinal cord injury patients, and individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis is expected in early 2012.

JUUL is an electronics company based in San Francisco that focuses on providing alternatives for adult smokers through its nicotine vaporizer products. Founded with the mission to eliminate combustible cigarettes, JUUL aims to offer a viable solution for the approximately one billion smokers worldwide. The company's offerings include a range of vapes and various free-base nicotine flavors derived from natural oils and extracts, designed to deliver a satisfying smoking experience while reducing the harmful effects associated with traditional tobacco use. JUUL has reported that hundreds of thousands of smokers have successfully transitioned to its products, with plans to support millions more in making the switch in the future.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Nanotech Biomachines specializes in the development of advanced sensor technology aimed at transforming therapeutic discovery and development processes. By utilizing modern electronic materials and straightforward membrane preparations, the company achieves high sensitivity and specificity in its measurements. Its innovative approach employs naive biology to enable real-time, mass-independent, cell-free, and label-free detection of interactions with integral membrane proteins (IMPs). This technology offers a direct electronic output and utilizes native IMPs within fluid membranes, providing essential tools for clients engaged in the discovery and development of 21st-century medicines.

Sandstone Diagnostics offers a centrifuge system that provides plasma and serum collection at-home and the point-of-care. It specializes in the fields of clinical diagnostics, home healthcare, and fertility. It was founded in 2012 and headquartered in Pleasanton, California.

Catheter Connections, Inc. specializes in developing vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and based in Salt Lake City, Utah, the company offers the DualCap System, which includes user-friendly, single-use disinfecting caps designed to protect IV catheter access points. The system helps healthcare facilities combat IV catheter-related bloodstream infections by effectively disinfecting IV tubing end connectors and needle-free valves. Catheter Connections markets its products through a network of sales representatives, focusing on providing integrated solutions for infection control in healthcare settings across the United States. As of early 2017, the company operates as a subsidiary of Merit Medical Systems, Inc.

Cadence Biomedical, headquartered in Seattle, WA, is an early-stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life. Cadence Biomedical's primary commercial product, Kickstart, is a neurorehabilitation device designed to accelerate recovery to walking in stroke, multiple sclerosis, spinal cord injury patients, and individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis is expected in early 2012.

Cadence Biomedical, headquartered in Seattle, WA, is an early-stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life. Cadence Biomedical's primary commercial product, Kickstart, is a neurorehabilitation device designed to accelerate recovery to walking in stroke, multiple sclerosis, spinal cord injury patients, and individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis is expected in early 2012.

Cadence Biomedical, headquartered in Seattle, WA, is an early-stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life. Cadence Biomedical's primary commercial product, Kickstart, is a neurorehabilitation device designed to accelerate recovery to walking in stroke, multiple sclerosis, spinal cord injury patients, and individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis is expected in early 2012.

OncoHealth designs screening devices that detects and diagnoses cancer. Its devices focus on the development of protein bio-markers for screening and diagnostics of cervical cancer and other HPV-associated cancers, enabling medical professionals to monitor, diagnose, and treat cancer.

Catheter Connections, Inc. specializes in developing vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and based in Salt Lake City, Utah, the company offers the DualCap System, which includes user-friendly, single-use disinfecting caps designed to protect IV catheter access points. The system helps healthcare facilities combat IV catheter-related bloodstream infections by effectively disinfecting IV tubing end connectors and needle-free valves. Catheter Connections markets its products through a network of sales representatives, focusing on providing integrated solutions for infection control in healthcare settings across the United States. As of early 2017, the company operates as a subsidiary of Merit Medical Systems, Inc.

OncoHealth designs screening devices that detects and diagnoses cancer. Its devices focus on the development of protein bio-markers for screening and diagnostics of cervical cancer and other HPV-associated cancers, enabling medical professionals to monitor, diagnose, and treat cancer.

Cadence Biomedical, headquartered in Seattle, WA, is an early-stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life. Cadence Biomedical's primary commercial product, Kickstart, is a neurorehabilitation device designed to accelerate recovery to walking in stroke, multiple sclerosis, spinal cord injury patients, and individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis is expected in early 2012.

Catheter Connections, Inc. specializes in developing vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and based in Salt Lake City, Utah, the company offers the DualCap System, which includes user-friendly, single-use disinfecting caps designed to protect IV catheter access points. The system helps healthcare facilities combat IV catheter-related bloodstream infections by effectively disinfecting IV tubing end connectors and needle-free valves. Catheter Connections markets its products through a network of sales representatives, focusing on providing integrated solutions for infection control in healthcare settings across the United States. As of early 2017, the company operates as a subsidiary of Merit Medical Systems, Inc.

OncoHealth designs screening devices that detects and diagnoses cancer. Its devices focus on the development of protein bio-markers for screening and diagnostics of cervical cancer and other HPV-associated cancers, enabling medical professionals to monitor, diagnose, and treat cancer.

Catheter Connections, Inc. specializes in developing vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and based in Salt Lake City, Utah, the company offers the DualCap System, which includes user-friendly, single-use disinfecting caps designed to protect IV catheter access points. The system helps healthcare facilities combat IV catheter-related bloodstream infections by effectively disinfecting IV tubing end connectors and needle-free valves. Catheter Connections markets its products through a network of sales representatives, focusing on providing integrated solutions for infection control in healthcare settings across the United States. As of early 2017, the company operates as a subsidiary of Merit Medical Systems, Inc.

IMI Intelligent Medical Implants develops and markets intelligent retinal implant systems for degenerative retinal disorders. The company offers The Intelligent Retinal Implant System, an adaptive visual prosthesis that bridges and replaces the defective information processing function of the real retina in patients with retinal degeneration. IMI Intelligent Medical Implants was founded in 2002 and is based in Zug, Switzerland.